Sarepta Therapeutics, Inc. SRPT Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s change in inventories?
- Sarepta Therapeutics, Inc. (SRPT) reported change in inventories of $69.76M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s change in inventories changed year-over-year?
- Sarepta Therapeutics, Inc.'s change in inventories decreased by 60.7% year-over-year, from $177.36M to $69.76M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s change in inventories?
- Over 4 years (2021 to 2025), Sarepta Therapeutics, Inc.'s change in inventories has grown at a 39.8% compound annual growth rate (CAGR), from $83.77M to $319.57M.
- What does change in inventories mean?
- Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.